HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claes Malm Selected Research

Blast Crisis (Blast Phase)

1/2004Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claes Malm Research Topics

Disease

4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2021 - 01/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2021 - 09/2012
1Mastocytosis
02/2021
1Systemic Mastocytosis
02/2021
1Polycythemia Vera
02/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2011
1Primary Myelofibrosis (Myelosclerosis)
11/2006
1Philadelphia Chromosome
09/2006
1Blast Crisis (Blast Phase)
01/2004
1Weight Loss (Weight Reduction)
04/2003
1Disease Progression
09/2002

Drug/Important Bio-Agent (IBA)

2Hydroxyurea (Hydrea)FDA LinkGeneric
01/2005 - 01/2004
1Imatinib Mesylate (Gleevec)FDA Link
09/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2006
1LenograstimIBA
09/2006
1InterferonsIBA
01/2005
1Busulfan (Busulfex)FDA Link
01/2004
1Anti-Bacterial Agents (Antibiotics)IBA
04/2003

Therapy/Procedure

4Stem Cell Transplantation
02/2021 - 01/2005
3Transplantation
02/2021 - 09/2002
2Drug Therapy (Chemotherapy)
09/2006 - 01/2005
1Homologous Transplantation
11/2006